RE:Looks Like Sun Pharma Is Going All Out on Absorbica LDThis is the first line of treatment being prescribed by derms. My daughter was twice. Other than that CF-101 phase 3 early data collection ended on Feb 15. With full results in december. Lets see where that goes. Knight, Bausch, Advanz are the only 3 companies in canada that can buyout cipher. I dont see any other listed on tsx. Its a great fit for knight and Advanz. But doesnt makes sense for Bausch to allow these companies to get access to its products including trulance ( galephar is also theirs). Meduxus, Crescita are smaller but have dedicated salesforce in derm or speciality pharma. So buyout for now looks remote. But does cipher needs a buyout? May be not. Shareholders needs a better stock price ..thats for sure :). Get the trulance issue resolved and we will have much better visibility.